Alembic Pharmaceuticals Limited (APLLTD) — Board Meeting

· NSE 🟡 Notable Neutral
📢 Key Event
Appointment of Sujit Jaysukh Bhayani as Additional Director and Non-Executive Independent Director
🔄 What Changed
New independent director appointed to board
🔮 What's Next
Subject to shareholder approval at upcoming AGM
💡 Investor Takeaway
Adds independent oversight to board composition

Alembic Pharmaceuticals announced the appointment of Sujit Jaysukh Bhayani as an Additional Director and Non-Executive Independent Director effective 18 June 2026 for a five-year term, subject to shareholder approval at the upcoming AGM. The appointment follows the recommendation of the Nomination and Remuneration Committee and complies with SEBI Listing Regulations.

📄 View Original Announcement (PDF)

About Alembic Pharmaceuticals Limited (APLLTD)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹15,412.51 Cr P/E: 22.9 ROE: 11.8% ROCE: 11.2%

View full APLLTD stock details →

📡 Get AI alerts when APLLTD files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track APLLTD — Free

📊 More APLLTD filings

See all APLLTD filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when APLLTD files new disclosures

Track APLLTD filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track APLLTD — Free

Free account · 2 AI queries/day